Ethylene

Ethylene

SCHEMBL6996024

C=C.CCOC(C)OCC.COc1ccc2c(c1)S(=O)(=O)N(CCCN1CCN(c3ccc(F)cc3)CC1)CC2=O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.42
HTR1A P08908 4/20 0.42
DRD2 P14416 3/20 0.42
HTR7 P34969 5/20 0.41
HTR2A P28223 4/20 0.41
HTR2C P28335 3/20 0.41
DRD4 P21917 1/20 0.40
TP53 P04637 1/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR6 P50406 1/20 0.39
ABCB1 P08183 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6996869 0.94 HTR1A (0.44) ALOX15HTR1ADRD2HTR7HTR2A
Ethylene SCHEMBL6994468 0.90 DRD2 (0.41) HTR1ADRD2HTR7HTR2AHTR2C
Ethylene SCHEMBL6995999 0.88 DRD2 (0.45) HTR1ADRD2HTR7HTR2AHTR2C
Ethylene SCHEMBL6987484 0.87 DRD2 (0.56) HTR1ADRD2HTR7HTR2ADRD4
Ethylene SCHEMBL6998179 0.86 DRD2 (0.47) HTR1ADRD2HTR7HTR2AHTR2C
Ethylene SCHEMBL6995216 0.86 DRD2 (0.51) DRD2HTR2AHTR2CSMN1; SMN2ALDH1A1
Ethylene SCHEMBL6996875 0.85 CACNA1G (0.41) HTR1ADRD2HTR7HTR2AHTR2C
Ethylene SCHEMBL6997328 0.84 HTR1A (0.58) HTR1ADRD2HTR7HTR2ADRD4
Ethylene SCHEMBL6995181 0.83 DRD2 (0.43) ALOX15HTR1ADRD2HTR7HTR2A
Ethylene SCHEMBL6991302 0.83 TDP1 (0.42) HTR1ADRD2HTR7HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
EP-0749967-B1 Substituted benzothiazine derivative SUNTORY LTD (JP) 2003-01-22 EP disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
EP-0749967-A1 Substituted benzothiazine derivative SUNTORY LIMITED (JP) 1996-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 ALOX15 1918/4885HTR1A 7/4885DRD2 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.